The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Interleukin 10 protects mice from lethal endotoxemia.
Open accessAbstract
Interleukin 10 (IL-10) decreases production of IL-1, IL-6, and tumor necrosis factor alpha (TNF-alpha) in vitro, and neutralization of IL-10 in mice leads to elevation of the same monokines. We test here whether this monokine-suppressing property of IL-10 confers on it the capacity to protect mice from lipopolysaccharide-induced shock, a monokine-mediated inflammatory reaction. A single injection of 0.5-1 microgram of recombinant murine IL-10 reproducibly protected BALB/c mice from a lethal intraperitoneal injection of endotoxin. This result was obtained whether the IL-10 was administered concurrently with, or 30 min after the injection of endotoxin. The protective effect of IL-10 was reversed by prior injection of neutralizing anti-IL-10 antibodies, and correlated with a substantial decrease in endotoxin-induced TNF-alpha release. These data implicate IL-10 as a candidate for treatment of bacterial sepsis, and more generally as an effective antiinflammatory reagent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
de Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C. G., & de Vries, J. E. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.5.1209 · Cited by 3,762
IL-10 inhibits cytokine production by activated macrophages
Fiorentino, D. F., Zlotnik, A., Mosmann, T. R., Howard, M., & O’Garra, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.11.3815 · Cited by 2,888
Self-citationFiorentino, D. F., Bond, M. W., & Mosmann, T. R. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.6.2081 · Cited by 2,733
Beutler, B., Milsark, I. W., & Cerami, A. C. (1985) · Science · doi:10.1126/science.3895437 · Cited by 2,352
Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes
Rousset, F., Garcia, E., Defrance, T., Péronne, C., Vezzio, N., Hsu, D. H., Kastelein, R., Moore, K. W., & Banchereau, J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1890 · Cited by 1,238
Macrophage deactivation by interleukin 10.
Bogdan, C., Vodovotz, Y., & Nathan, C. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.6.1549 · Cited by 1,238
Treatment of Gram-Negative Bacteremia and Shock with Human Antiserum to a Mutant Escherichia coli
Ziegler, E. J., McCutchan, J. A., Fierer, J., Glauser, M. P., Sadoff, J. C., Douglas, H., & Braude, A. I. (1982) · New England Journal of Medicine · doi:10.1056/nejm198211113072001 · Cited by 1,046
Vieira, P., de Waal-Malefyt, R., Dang, M. N., Johnson, K. E., Kastelein, R., Fiorentino, D. F., deVries, J. E., Roncarolo, M. G., Mosmann, T. R., & Moore, K. W. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.4.1172 · Cited by 739
Biological properties of interleukin 10
Howard, M., & O'Garra, A. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90153-x · Cited by 640
Self-citationLy‐1 B (B‐1) cells are the main source of B cell‐derived interleukin 10
O'garra, A., Chang, R., Go, N., Hastings, R., Haughton, G., & Howard, M. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220314 · Cited by 526
Self-citation
Cited by
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
Functional diversity of helper T lymphocytes
Abbas, A. K., Murphy, K. M., & Sher, A. (1996) · Nature · doi:10.1038/383787a0 · Cited by 4,450
Interleukin-10-deficient mice develop chronic enterocolitis
Kühn, R., Löhler, J., Rennick, D., Rajewsky, K., & Müller, W. (1993) · Cell · doi:10.1016/0092-8674(93)80068-p · Cited by 4,274
Baumann, H., & Gauldie, J. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90137-6 · Cited by 2,899
Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway
Otterbein, L. E., Bach, F. H., Alam, J., Soares, M., Tao Lu, H., Wysk, M., Davis, R. J., Flavell, R. A., & Choi, A. M. K. (2000) · Nature Medicine · doi:10.1038/74680 · Cited by 2,153
Powrie, F., Leach, M. W., Mauze, S., Menon, S., Barcomb Caddle, L., & Coffman, R. L. (1994) · Immunity · doi:10.1016/1074-7613(94)90045-0 · Cited by 1,146
Self-citationThe role of the endothelium in severe sepsis and multiple organ dysfunction syndrome
Aird, W. C. (2003) · Blood · doi:10.1182/blood-2002-06-1887 · Cited by 1,131
Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome
Bhatia, M., & Moochhala, S. (2004) · The Journal of Pathology · doi:10.1002/path.1491 · Cited by 1,095
The production of cytokines by polymorphonuclear neutrophils
Cassatella, M. A. (1995) · Immunology Today · doi:10.1016/0167-5699(95)80066-2 · Cited by 904
NF-κB activation as a pathological mechanism of septic shock and inflammation
Liu, S. F., & Malik, A. B. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00477.2005 · Cited by 761
Cytokines in Sepsis: Potent Immunoregulators and Potential Therapeutic Targets—An Updated View
Schulte, W., Bernhagen, J., & Bucala, R. (2013) · Mediators of Inflammation · doi:10.1155/2013/165974 · Cited by 745
MAPK phosphatases — regulating the immune response
Liu, Y., Shepherd, E. G., & Nelin, L. D. (2007) · Nature Reviews Immunology · doi:10.1038/nri2035 · Cited by 679
Finkelman, F. D., Shea-Donohue, T., Goldhill, J., Sullivan, C. A., Morris, S. C., Madden, K. B., Gause, W. C., & Urban, J. F. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.505 · Cited by 643
Gender Differences in Human Sepsis
Schröder, J. (1998) · Archives of Surgery · doi:10.1001/archsurg.133.11.1200 · Cited by 613
Chi, H., Barry, S. P., Roth, R. J., Wu, J. J., Jones, E. A., Bennett, A. M., & Flavell, R. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510965103 · Cited by 569
Inducible Nitric Oxide Synthase and Inflammatory Diseases
Zamora, R., Vodovotz, Y., & Billiar, T. R. (2000) · Molecular Medicine · doi:10.1007/bf03401781 · Cited by 558
Dysregulation of inflammatory responses by chronic circadian disruption
Castanon-Cervantes, O., Wu, M., Ehlen, J. C., Paul, K., Gamble, K. L., Johnson, R. L., Besing, R. C., Menaker, M., Gewirtz, A. T., & Davidson, A. J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001026 · Cited by 542
Berg, D. J., Kühn, R., Rajewsky, K., Müller, W., Menon, S., Davidson, N., Grünig, G., & Rennick, D. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118290 · Cited by 535
Self-citationInflammatory mediators in acute pancreatitis
Bhatia, M., Brady, M., Shokuhi, S., Christmas, S., Neoptolemos, J. P., & Slavin, J. (2000) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(200002)190:2<117::aid-path494>3.0.co;2-k · Cited by 534
Immunoregulatory role of interleukin 10 in rheumatoid arthritis.
Katsikis, P. D., Chu, C. Q., Brennan, F. M., Maini, R. N., & Feldmann, M. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.5.1517 · Cited by 529
van der Poll, T., Coyle, S. M., Barbosa, K., Braxton, C. C., & Lowry, S. F. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118469 · Cited by 519
Cassatella, M. A., Meda, L., Bonora, S., Ceska, M., & Constantin, G. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.6.2207 · Cited by 507
Imtiyaz, H. Z., Williams, E. P., Hickey, M. M., Patel, S. A., Durham, A. C., Yuan, L.-J., Hammond, R., Gimotty, P. A., Keith, B., & Simon, M. C. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39506 · Cited by 461
Randow, F., Syrbe, U., Meisel, C., Krausch, D., Zuckermann, H., Platzer, C., & Volk, H. D. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.5.1887 · Cited by 445
Understanding and exploiting the endogenous interleukin-10/STAT3-mediated anti-inflammatory response
MURRAY, P. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.01.010 · Cited by 436
Lyke, K. E., Burges, R., Cissoko, Y., Sangare, L., Dao, M., Diarra, I., Kone, A., Harley, R., Plowe, C. V., Doumbo, O. K., et al. (2004) · Infection and Immunity · doi:10.1128/iai.72.10.5630-5637.2004 · Cited by 434
Donnelly, R. P., Dickensheets, H., & Finbloom, D. S. (1999) · Journal of Interferon & Cytokine Research · doi:10.1089/107999099313695 · Cited by 413
The Compensatory Anti-inflammatory Response Syndrome (CARS) in Critically Ill Patients
Ward, N. S., Casserly, B., & Ayala, A. (2008) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2008.06.010 · Cited by 406
Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury
Deng, J., Kohda, Y., Chiao, H., Wang, Y., Hu, X., Hewitt, S. M., Miyaji, T., Mcleroy, P., Nibhanupudy, B., Li, S., et al. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00043.x · Cited by 399
Elevated soluble CD14 receptors and altered cytokines in chronic heart failure
Anker, S. D., Egerer, K. R., Volk, H.-D., Kox, W. J., Poole-Wilson, P. A., & Coats, A. J. S. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00159-8 · Cited by 392
Immunosuppressive and Anti-inflammatory Properties of Interleukin 10
de Vries, J. E. (1995) · Annals of Medicine · doi:10.3109/07853899509002465 · Cited by 391
Niessner, M., & Volk, B. A. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1995.tb03130.x · Cited by 388
Hypoxia-Inducible Factors as Essential Regulators of Inflammation
Imtiyaz, H. Z., & Simon, M. C. (2010) · Current Topics in Microbiology and Immunology · doi:10.1007/82_2010_74 · Cited by 379
Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease
Schreiber, S., Heinig, T., Thiele, H.-G., & Raedler, A. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90692-4 · Cited by 372
Interleukin-10 production during septicaemia
Marchant, A., Goldman, M., Devière, J., Byl, B., Vincent, J. L., & Groote, D. D. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91584-9 · Cited by 368
Strassmann, G., Patil-Koota, V, Finkelman, F., Fong, M., & Kambayashi, T. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.6.2365 · Cited by 367
Interleukin‐10 prevents experimental allergic encephalomyelitis in rats
Rott, O., Fleischer, B., & Cash, E. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240629 · Cited by 367
Semple, J., Milev, Y., Cosgrave, D., Mody, M., Hornstein, A., Blanchette, V, & Freedman, J. (1996) · Blood · doi:10.1182/blood.v87.10.4245.bloodjournal87104245 · Cited by 363
Monocyte deactivation-rationale for a new therapeutic strategy in sepsis
Volk, H. D., Reinke, P., Krausch, D., Zuckermann, H., Asadullah, K., Müller, J. M., Döcke, W. D., & Kox, W. J. (1996) · Intensive Care Medicine · doi:10.1007/bf01743727 · Cited by 361
β-Defensins: Multifunctional Modulators of Infection, Inflammation and More?
Semple, F., & Dorin, J. R. (2012) · Journal of Innate Immunity · doi:10.1159/000336619 · Cited by 346
Apoptosis in the vasculature: mechanisms and functional importance
Mallat, Z., & Tedgui, A. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703407 · Cited by 343
Reversal of Proinflammatory Responses by Ligating the Macrophage Fcγ Receptor Type I
Sutterwala, F. S., Noel, G. J., Salgame, P., & Mosser, D. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.1.217 · Cited by 327
IL-10: Master Switch from Tumor-Promoting Inflammation to Antitumor Immunity
Oft, M. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0214 · Cited by 322
“Treatment with IL-10 protects mice fromexperimental endotoxemia (13).”
BackgroundProinflammatory Effects of IL-10 During Human Endotoxemia
Lauw, F. N., Pajkrt, D., Hack, C. E., Kurimoto, M., van Deventer, S. J. H., & van der Poll, T. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.5.2783 · Cited by 318
Regulation of Macrophage Chemokine Expression by Lipopolysaccharide In Vitro and In Vivo
Kopydlowski, K. M., Salkowski, C. A., Cody, M. J., van Rooijen, N., Major, J., Hamilton, T. A., & Vogel, S. N. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1537 · Cited by 313
Studies with IL-10-/- mice: an overview
Rennick, D. M., Fort, M. M., & Davidson, N. J. (1997) · Journal of Leukocyte Biology · doi:10.1002/jlb.61.4.389 · Cited by 302
Oberholzer, A., Oberholzer, C., & Moldawer, L. L. (2002) · Critical Care Medicine · doi:10.1097/00003246-200201001-00008 · Cited by 298
New insights into the molecular mechanism of interleukin-10-mediated immunosuppression
Grütz, G. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0904484 · Cited by 296
Marchant, A., Bruyns, C., Vandenabeele, P., Ducarme, M., Gérard, C., Delvaux, A., De Groote, D., Abramowicz, D., Velu, T., & Goldman, M. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240524 · Cited by 294
Bacterial DNA-Induced NK Cell IFN-γ Production Is Dependent on Macrophage Secretion of IL-12
Chace, J. H., Hooker, N. A., Mildenstein, K. L., Krieg, A. M., & Cowdery, J. S. (1997) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1997.4380 · Cited by 291
IL-10 Is a Major Mediator of Sepsis-Induced Impairment in Lung Antibacterial Host Defense
Steinhauser, M. L., Hogaboam, C. M., Kunkel, S. L., Lukacs, N. W., Strieter, R. M., & Standiford, T. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.1.392 · Cited by 289
Endogenous IL-10 protects mice from death during septic peritonitis
van der Poll, T., Marchant, A., Buurman, W. A., Berman, L., Keogh, C. V., Lazarus, D. D., Nguyen, L., Goldman, M., Moldawer, L. L., & Lowry, S. F. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.11.5397 · Cited by 285
Cassatella, M. A., Meda, L., Gasperini, S., Calzetti, F., & Bonora, S. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.5.1695 · Cited by 284
Foey, A. D., Parry, S. L., Williams, L. M., Feldmann, M., Foxwell, B. M. J., & Brennan, F. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.2.920 · Cited by 283
Zhang, H.-L., Yu, L.-X., Yang, W., Tang, L., Lin, Y., Wu, H., Zhai, B., Tan, Y.-X., Shan, L., Liu, Q., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.06.011 · Cited by 281
“Some studies have demonstrated that IL-10 can protect mice from lethal endotoxemia when administered concomitantly or following LPS challenge [28].”
BackgroundHack, C. E., Aarden, L. A., & Thus, L. G. (1997) · Advances in Immunology · doi:10.1016/s0065-2776(08)60597-0 · Cited by 280
Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice.
Zuany-Amorim, C., Hailé, S., Leduc, D., Dumarey, C., Huerre, M., Vargaftig, B. B., & Pretolani, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117966 · Cited by 276
Scorpion Venom and the Inflammatory Response
Petricevich, V. L. (2010) · Mediators of Inflammation · doi:10.1155/2010/903295 · Cited by 273
Berlato, C., Cassatella, M. A., Kinjyo, I., Gatto, L., Yoshimura, A., & Bazzoni, F. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.12.6404 · Cited by 267
Class II cytokine receptors and their ligands: Key antiviral and inflammatory modulators
Renauld, J.-C. (2003) · Nature Reviews Immunology · doi:10.1038/nri1153 · Cited by 265
Reversing Lipopolysaccharide Toxicity by Ligating the Macrophage Fcγ Receptors
Gerber, J. S., & Mosser, D. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6861 · Cited by 263
Interleukin‐10 inhibition of the progression of established collagen‐induced arthritis
Walmsley, M., Katsikis, P. D., Abney, E., Parry, S., Williams, R. O., Maini, R. N., & Feldmann, M. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390318 · Cited by 261
Pro-and Anti-inflammatory Cytokines in Rheumatoid Arthritis
Isomäki, P., & Punnonen, J. (1997) · Annals of Medicine · doi:10.3109/07853899709007474 · Cited by 260
Interieukin-10 Impairs Host Defense in Murine Pneumococcal Pneumonia
van der Poll, T., Marchant, A., Keogh, C. V., Goldman, M., & Lowry, S. F. (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/174.5.994 · Cited by 255
Why immunomodulatory therapies have not worked in sepsis
Abraham, E. (1999) · Intensive Care Medicine · doi:10.1007/s001340050903 · Cited by 252
Carrillo‐Vico, A., Lardone, P. J., Naji, L., Fernández‐Santos, J. M., Martín‐Lacave, I., Guerrero, J. M., & Calvo, J. R. (2005) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2005.00265.x · Cited by 204
Interleukin-10 potential benefits and possible risks in clinical infectious diseases
Opal, S. M., Wherry, J. C., & Grint, P. (1998) · Clinical Infectious Diseases · doi:10.1086/515032 · Cited by 114
“IL-10 clearly plays a protective role following endotoxin challenge in mice [40-42, 92, 93] and in primate models [39].”
BackgroundBiologic Control of Injury and Inflammation: Much More than Too Little or Too Late
Guirao, X., & Lowry, S. F. (1996) · World Journal of Surgery · doi:10.1007/s002689900069 · Cited by 102
“IL-10 suppresses LPS-induced production of TNF by mononuclear cells during in vitro [77, 83], in vivo [84, 85], and ex vivo [86] experiments.”
BackgroundGenetic polymorphisms in sepsis
Dahmer, M. K., Randolph, A., Vitali, S., & Quasney, M. W. (2005) · Pediatric Critical Care Medicine · doi:10.1097/01.pcc.0000161970.44470.c7 · Cited by 101
“The antiinflammatory effects of IL-10 have been demonstrated in animal models of sepsis in which neutralization of IL-10 results in an exaggerated proinflammatory response and death, while administration of IL-10 confers protection (4, 132, 133).”
BackgroundSpermine inhibition of monocyte activation and inflammation
Zhang, M., Borovikova, L. V., Wang, H., Metz, C., & Tracey, K. J. (1999) · Molecular Medicine · doi:10.1007/bf03402072 · Cited by 92
Kimura, F., Shimizu, H., Yoshidome, H., Ohtsuka, M., Kato, A., Yoshitomi, H., Nozawa, S., Furukawa, K., Mitsuhashi, N., Sawada, S., et al. (2006) · Journal of Surgical Research · doi:10.1016/j.jss.2005.10.025 · Cited by 62
Metadata
- Authors
- Howard, M., Muchamuel, T., Andrade, S., & Menon, S.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1993-04-01
- Volume
- 177
- Issue
- 4
- Pages
- 1205-1208
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2105960411
- Cited by
- 792
- References
- 24
- FWCI
- 41.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.